尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Hsu Jason, 董事. Director active across 1 company, notably Immix Biopharma, Inc.. Cumulatively, 7 reports have been recorded. Split: 6 buys · 0 sell. Total volume traded: €256k. History available since 20 December 2021. The latest transaction was disclosed on 20 December 2024 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Hsu Jason is Administrateur and Director at Immix Biopharma, Inc. He has 7 filings in total. Across the 7 most recent sampled filings, buys amount to EUR 256082 and sells to EUR 0, and the period runs from 2021-12-20 to 2024-12-26. The modal transaction nature is Acquisition.